For the year ending 2025-12-31, DMIIR has $504,959,837 in assets. $17,800,864 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 223 | |||
| Prepaid expenses | 25,814 | |||
| Total current assets | 26,037 | |||
| Cash and investments held in trust account | 504,933,800 | |||
| Total non-current assets | 504,933,800 | |||
| Total assets | 504,959,837 | |||
| Accounts payable | 99,359 | |||
| Accrued expenses | 88,343 | |||
| Accrued offering costs | 113,162 | |||
| Total current liabilities | 300,864 | |||
| Deferred underwriting fee payable | 17,500,000 | |||
| Total non-current liabilities | 17,500,000 | |||
| Total liabilities | 17,800,864 | |||
| Ordinary shares subject to possible redemption, 50,000,000 shares at redemption value of 10.00 and 0 per share as of december 31, 2025 and 2024, respectively | 504,933,800 | |||
| Ordinary shares, 0.0001 par value 220,000,000 shares authorized 13,700,000 and 14,375,000 shares issued and outstanding, excluding 50,000,000 and 0 shares subject to redemption as of december 31, 2025 and 2024, respectively | 1,369 | |||
| Accumulated deficit | -17,776,196 | |||
| Total shareholders deficit | -17,774,827 | |||
| Total liabilities, ordinary shares subject to possible redemption, and shareholders deficit | 504,959,837 | |||
Drugs Made In America Acquisition II Corp. (DMIIR)
Drugs Made In America Acquisition II Corp. (DMIIR)